Mu-Kuan Chen1. 1. Department of Otorhinolaryngology, Head and Neck Surgery, Changhua Christian Hospital, Changhua and Chang Jung Christian University, Tainan, Taiwan. 53780@cch.org.tw
Abstract
CONCLUSIONS: Sinonasal malignancies without far lateral extension, intracranial invasion or orbital infiltration can be safely excised and reconstructed endoscopically with a satisfactory outcome. OBJECTIVES: To evaluate the safety and efficacy of strictly endoscopic resection of malignant sinonasal neoplasms. PATIENTS AND METHODS: Seven patients with sinonasal malignancies had received a minimally invasive endoscopic resection. Among them, two cases invaded the skull base. All patients were operated with curative intent. RESULTS: All the tumors were removed successfully by strictly endoscopic surgery. Two patients who had invasion of the skull base (28.6%) accepted postoperative radiotherapy. No complications associated with the operation occurred. The patients were followed up for 15-57 months (average 36.4 months). No local recurrence was noted in this series to date. The disease-free survival rate was 100% at a mean follow-up duration of 36.4 months.
CONCLUSIONS:Sinonasal malignancies without far lateral extension, intracranial invasion or orbital infiltration can be safely excised and reconstructed endoscopically with a satisfactory outcome. OBJECTIVES: To evaluate the safety and efficacy of strictly endoscopic resection of malignant sinonasal neoplasms. PATIENTS AND METHODS: Seven patients with sinonasal malignancies had received a minimally invasive endoscopic resection. Among them, two cases invaded the skull base. All patients were operated with curative intent. RESULTS: All the tumors were removed successfully by strictly endoscopic surgery. Two patients who had invasion of the skull base (28.6%) accepted postoperative radiotherapy. No complications associated with the operation occurred. The patients were followed up for 15-57 months (average 36.4 months). No local recurrence was noted in this series to date. The disease-free survival rate was 100% at a mean follow-up duration of 36.4 months.
Authors: Zafar Sayed; Jocelyn C Migliacci; Jennifer R Cracchiolo; Christopher A Barker; Nancy Y Lee; Sean M McBride; Viviane S Tabar; Ian Ganly; Snehal G Patel; Luc T Morris; Benjamin R Roman; Alexander N Shoushtari; Marc A Cohen Journal: JAMA Otolaryngol Head Neck Surg Date: 2017-12-01 Impact factor: 6.223